 | • レポートコード：QFJ1-3819 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗喘息薬＆COPD薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、モノクローナル抗体、併用薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗喘息薬＆COPD薬の市場動向 ・企業の競争状況、市場シェア ・抗喘息薬＆COPD薬の種類別市場規模と予測2016-2027（抗炎症薬、モノクローナル抗体、併用薬） ・抗喘息薬＆COPD薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・抗喘息薬＆COPD薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗喘息薬＆COPD薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗喘息薬＆COPD薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗喘息薬＆COPD薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗喘息薬＆COPD薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Merck & Co、GlaxoSmithKline、Boehringer Ingelheim Gmbh、AstraZeneca、Roche、Teva Pharmaceutical、Vectura、Pfizer、Abbott、Mylan、Allergan、Cipla、Akorn） ・結論 |
The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The class of drugs includes Bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.
Market Analysis and Insights: Global Anti-Asthmatics and COPD Drugs Market
The global Anti-Asthmatics and COPD Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Asthmatics and COPD Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Asthmatics and COPD Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Asthmatics and COPD Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Asthmatics and COPD Drugs market.
Global Anti-Asthmatics and COPD Drugs Scope and Market Size
Anti-Asthmatics and COPD Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Asthmatics and COPD Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-inflammatory Drugs
Monoclonal Antibodies
Combination Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis AG
Merck & Co
GlaxoSmithKline
Boehringer Ingelheim Gmbh
AstraZeneca
Roche
Teva Pharmaceutical
Vectura
Pfizer
Abbott
Mylan
Allergan
Cipla
Akorn
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Asthmatics and COPD Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory Drugs
1.2.3 Monoclonal Antibodies
1.2.4 Combination Drugs
1.3 Market by Application
1.3.1 Global Anti-Asthmatics and COPD Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Asthmatics and COPD Drugs Market Perspective (2016-2027)
2.2 Anti-Asthmatics and COPD Drugs Growth Trends by Regions
2.2.1 Anti-Asthmatics and COPD Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Asthmatics and COPD Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Asthmatics and COPD Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Asthmatics and COPD Drugs Industry Dynamic
2.3.1 Anti-Asthmatics and COPD Drugs Market Trends
2.3.2 Anti-Asthmatics and COPD Drugs Market Drivers
2.3.3 Anti-Asthmatics and COPD Drugs Market Challenges
2.3.4 Anti-Asthmatics and COPD Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Asthmatics and COPD Drugs Players by Revenue
3.1.1 Global Top Anti-Asthmatics and COPD Drugs Players by Revenue (2016-2021)
3.1.2 Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Asthmatics and COPD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Asthmatics and COPD Drugs Revenue
3.4 Global Anti-Asthmatics and COPD Drugs Market Concentration Ratio
3.4.1 Global Anti-Asthmatics and COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Asthmatics and COPD Drugs Revenue in 2020
3.5 Anti-Asthmatics and COPD Drugs Key Players Head office and Area Served
3.6 Key Players Anti-Asthmatics and COPD Drugs Product Solution and Service
3.7 Date of Enter into Anti-Asthmatics and COPD Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Asthmatics and COPD Drugs Breakdown Data by Type
4.1 Global Anti-Asthmatics and COPD Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anti-Asthmatics and COPD Drugs Forecasted Market Size by Type (2022-2027)
5 Anti-Asthmatics and COPD Drugs Breakdown Data by Application
5.1 Global Anti-Asthmatics and COPD Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anti-Asthmatics and COPD Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Asthmatics and COPD Drugs Market Size (2016-2027)
6.2 North America Anti-Asthmatics and COPD Drugs Market Size by Type
6.2.1 North America Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021)
6.2.2 North America Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027)
6.2.3 North America Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2027)
6.3 North America Anti-Asthmatics and COPD Drugs Market Size by Application
6.3.1 North America Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021)
6.3.2 North America Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027)
6.3.3 North America Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2027)
6.4 North America Anti-Asthmatics and COPD Drugs Market Size by Country
6.4.1 North America Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021)
6.4.2 North America Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Asthmatics and COPD Drugs Market Size (2016-2027)
7.2 Europe Anti-Asthmatics and COPD Drugs Market Size by Type
7.2.1 Europe Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2027)
7.3 Europe Anti-Asthmatics and COPD Drugs Market Size by Application
7.3.1 Europe Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2027)
7.4 Europe Anti-Asthmatics and COPD Drugs Market Size by Country
7.4.1 Europe Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Type
8.2.1 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Application
8.3.1 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Region
8.4.1 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Asthmatics and COPD Drugs Market Size (2016-2027)
9.2 Latin America Anti-Asthmatics and COPD Drugs Market Size by Type
9.2.1 Latin America Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2027)
9.3 Latin America Anti-Asthmatics and COPD Drugs Market Size by Application
9.3.1 Latin America Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2027)
9.4 Latin America Anti-Asthmatics and COPD Drugs Market Size by Country
9.4.1 Latin America Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Type
10.2.1 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Application
10.3.1 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Country
10.4.1 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Anti-Asthmatics and COPD Drugs Introduction
11.1.4 Novartis AG Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Anti-Asthmatics and COPD Drugs Introduction
11.2.4 Merck & Co Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Anti-Asthmatics and COPD Drugs Introduction
11.3.4 GlaxoSmithKline Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Boehringer Ingelheim Gmbh
11.4.1 Boehringer Ingelheim Gmbh Company Details
11.4.2 Boehringer Ingelheim Gmbh Business Overview
11.4.3 Boehringer Ingelheim Gmbh Anti-Asthmatics and COPD Drugs Introduction
11.4.4 Boehringer Ingelheim Gmbh Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.4.5 Boehringer Ingelheim Gmbh Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Anti-Asthmatics and COPD Drugs Introduction
11.5.4 AstraZeneca Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Anti-Asthmatics and COPD Drugs Introduction
11.6.4 Roche Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Anti-Asthmatics and COPD Drugs Introduction
11.7.4 Teva Pharmaceutical Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Vectura
11.8.1 Vectura Company Details
11.8.2 Vectura Business Overview
11.8.3 Vectura Anti-Asthmatics and COPD Drugs Introduction
11.8.4 Vectura Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.8.5 Vectura Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-Asthmatics and COPD Drugs Introduction
11.9.4 Pfizer Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Anti-Asthmatics and COPD Drugs Introduction
11.10.4 Abbott Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Mylan
11.11.1 Mylan Company Details
11.11.2 Mylan Business Overview
11.11.3 Mylan Anti-Asthmatics and COPD Drugs Introduction
11.11.4 Mylan Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.11.5 Mylan Recent Development
11.12 Allergan
11.12.1 Allergan Company Details
11.12.2 Allergan Business Overview
11.12.3 Allergan Anti-Asthmatics and COPD Drugs Introduction
11.12.4 Allergan Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.12.5 Allergan Recent Development
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Anti-Asthmatics and COPD Drugs Introduction
11.13.4 Cipla Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.13.5 Cipla Recent Development
11.14 Akorn
11.14.1 Akorn Company Details
11.14.2 Akorn Business Overview
11.14.3 Akorn Anti-Asthmatics and COPD Drugs Introduction
11.14.4 Akorn Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021)
11.14.5 Akorn Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-Asthmatics and COPD Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory Drugs
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Combination Drugs
Table 5. Global Anti-Asthmatics and COPD Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-Asthmatics and COPD Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-Asthmatics and COPD Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-Asthmatics and COPD Drugs Market Share by Regions (2016-2021)
Table 9. Global Anti-Asthmatics and COPD Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-Asthmatics and COPD Drugs Market Share by Regions (2022-2027)
Table 11. Anti-Asthmatics and COPD Drugs Market Trends
Table 12. Anti-Asthmatics and COPD Drugs Market Drivers
Table 13. Anti-Asthmatics and COPD Drugs Market Challenges
Table 14. Anti-Asthmatics and COPD Drugs Market Restraints
Table 15. Global Anti-Asthmatics and COPD Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-Asthmatics and COPD Drugs Market Share by Players (2016-2021)
Table 17. Global Top Anti-Asthmatics and COPD Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Asthmatics and COPD Drugs as of 2020)
Table 18. Ranking of Global Top Anti-Asthmatics and COPD Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-Asthmatics and COPD Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-Asthmatics and COPD Drugs Product Solution and Service
Table 22. Date of Enter into Anti-Asthmatics and COPD Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-Asthmatics and COPD Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-Asthmatics and COPD Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-Asthmatics and COPD Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Anti-Asthmatics and COPD Drugs Product
Table 65. Novartis AG Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Merck & Co Company Details
Table 68. Merck & Co Business Overview
Table 69. Merck & Co Anti-Asthmatics and COPD Drugs Product
Table 70. Merck & Co Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 71. Merck & Co Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Anti-Asthmatics and COPD Drugs Product
Table 75. GlaxoSmithKline Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Boehringer Ingelheim Gmbh Company Details
Table 78. Boehringer Ingelheim Gmbh Business Overview
Table 79. Boehringer Ingelheim Gmbh Anti-Asthmatics and COPD Drugs Product
Table 80. Boehringer Ingelheim Gmbh Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 81. Boehringer Ingelheim Gmbh Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Anti-Asthmatics and COPD Drugs Product
Table 85. AstraZeneca Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Anti-Asthmatics and COPD Drugs Product
Table 90. Roche Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Teva Pharmaceutical Company Details
Table 93. Teva Pharmaceutical Business Overview
Table 94. Teva Pharmaceutical Anti-Asthmatics and COPD Drugs Product
Table 95. Teva Pharmaceutical Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 96. Teva Pharmaceutical Recent Development
Table 97. Vectura Company Details
Table 98. Vectura Business Overview
Table 99. Vectura Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 100. Vectura Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Anti-Asthmatics and COPD Drugs Product
Table 104. Pfizer Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Abbott Company Details
Table 107. Abbott Business Overview
Table 108. Abbott Anti-Asthmatics and COPD Drugs Product
Table 109. Abbott Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 110. Abbott Recent Development
Table 111. Mylan Company Details
Table 112. Mylan Business Overview
Table 113. Mylan Anti-Asthmatics and COPD Drugs Product
Table 114. Mylan Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 115. Mylan Recent Development
Table 116. Allergan Company Details
Table 117. Allergan Business Overview
Table 118. Allergan Anti-Asthmatics and COPD Drugs Product
Table 119. Allergan Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 120. Allergan Recent Development
Table 121. Cipla Company Details
Table 122. Cipla Business Overview
Table 123. Cipla Anti-Asthmatics and COPD Drugs Product
Table 124. Cipla Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 125. Cipla Recent Development
Table 126. Akorn Company Details
Table 127. Akorn Business Overview
Table 128. Akorn Anti-Asthmatics and COPD Drugs Product
Table 129. Akorn Revenue in Anti-Asthmatics and COPD Drugs Business (2016-2021) & (US$ Million)
Table 130. Akorn Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Asthmatics and COPD Drugs Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory Drugs Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Combination Drugs Features
Figure 5. Global Anti-Asthmatics and COPD Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Anti-Asthmatics and COPD Drugs Report Years Considered
Figure 10. Global Anti-Asthmatics and COPD Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Anti-Asthmatics and COPD Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-Asthmatics and COPD Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Anti-Asthmatics and COPD Drugs Market Share by Regions (2022-2027)
Figure 14. Global Anti-Asthmatics and COPD Drugs Market Share by Players in 2020
Figure 15. Global Top Anti-Asthmatics and COPD Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Asthmatics and COPD Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Anti-Asthmatics and COPD Drugs Revenue in 2020
Figure 17. Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Anti-Asthmatics and COPD Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Anti-Asthmatics and COPD Drugs Market Share by Type (2016-2027)
Figure 21. North America Anti-Asthmatics and COPD Drugs Market Share by Application (2016-2027)
Figure 22. North America Anti-Asthmatics and COPD Drugs Market Share by Country (2016-2027)
Figure 23. United States Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-Asthmatics and COPD Drugs Market Share by Type (2016-2027)
Figure 27. Europe Anti-Asthmatics and COPD Drugs Market Share by Application (2016-2027)
Figure 28. Europe Anti-Asthmatics and COPD Drugs Market Share by Country (2016-2027)
Figure 29. Germany Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Anti-Asthmatics and COPD Drugs Market Share by Region (2016-2027)
Figure 39. China Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-Asthmatics and COPD Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Anti-Asthmatics and COPD Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Anti-Asthmatics and COPD Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Anti-Asthmatics and COPD Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Anti-Asthmatics and COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis AG Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 59. Merck & Co Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 61. Boehringer Ingelheim Gmbh Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 65. Vectura Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 67. Abbott Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 69. Allergan Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 70. Cipla Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 71. Akorn Revenue Growth Rate in Anti-Asthmatics and COPD Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…- 世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …
- 世界の抗パーキンソン薬市場規模・現状・予測（2021年-2027年） Anti-Parkinson Drugs are drugs used to treat Parkinson's disease. The most commonly used Anti-Parkinson Drugs act on the dopaminergic system of the striatum and basal ganglia, or are central muscarinic antagonists. Market Analysis and Insights: Global Anti-Parkinson Drugs Market The global Anti-Park…
- 世界のアンチエイジング薬＆デバイス市場規模・現状・予測（2021年-2027年） Aging is a natural phenomenon that is peculiar to all living things. However, accumulating findings indicate that senescence could be postponed or prevented by certain approaches. Substantial evidence has emerged supporting the possibility of radical human health and lifespan extension, in particula…